Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

被引：0
|
作者：
J. Hillengass
A. D. Ho
H. Goldschmidt
R. Waldherr
T. M. Moehler
机构：
[1] University Hospital of Heidelberg,Department of Hematology, Oncology and Rheumatology
[2] Gemeinschaftspraxis Pathologie,undefined
来源：
International Journal of Hematology | 2008年 / 88卷
关键词：
Cryoglobulinemia; Multiple myeloma; Stem cell transplantation; Immune reset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disappeared, elevated cryoglobulin levels persisted. Therefore we conclude that the relief of symptoms was caused by an immunomodulation induced by the autologous stem cell transplantation.
引用
收藏
页码：454 / 456
页数：2
相关论文
共 50 条
  • [41] Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)
    Sobejano, Eduardo
    De La Calle, Veronica Gonzalez
    Higuero, Victor
    Escalante, Fernando
    Garcia-Sanz, Ramon
    Presa, Daniel
    Azibeiro, Raul
    Fonseca, Marta
    Rey, Beatriz
    Puig, Noemi
    Gutierrez, Norma C.
    Leoz, Pilar
    Labrador, Jorge
    Aguilera, Carmen
    Alonso, Jose Maria Alonso
    Lopez, Rosa
    Mateo, Aranzazu Garcia
    Garcia, Alfonso
    Hernandez, Roberto
    Garcia, Abelardo Barez
    Davila, Julio
    Redondo, Elena
    Quiros, Victor
    Mateos, Maria-Victoria
    BLOOD, 2019, 134
  • [42] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
  • [43] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Sivaraj, D.
    Bacon, W.
    Long, G. D.
    Rizzieri, D. A.
    Horwitz, M. E.
    Sullivan, K. M.
    Kang, Y.
    Li, Z.
    Chao, N. J.
    Gasparetto, C.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 34 - 38
  • [44] High-dose idarubicine, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma. Comparison with an historical control
    Capria, S
    Ribersani, M
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Torromeo, MC
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S81 - S82
  • [45] HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH MULTIPLE-MYELOMA
    FERMAND, JP
    CHEVRET, S
    HENNEQUIN, C
    GEROTA, M
    BENBUNAN, M
    BROUET, JC
    INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 : 141 - 141
  • [46] Use of pegfilgrastim after high-dose melphalan and autologous peripheral blood stem cell transplant in multiple myeloma patients
    Messina, G
    Martino, M
    Console, G
    Praticò, G
    Massara, E
    Moscato, T
    Pucci, G
    Irrera, G
    Callea, V
    Quartarone, E
    Stelitano, C
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S306 - S306
  • [47] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [48] High-dose therapy followed by autologous peripheral blood stem cell transplantation in myeloma associated neuropathy
    Kilidireas, C
    Papadimitriou, C
    Karandreas, N
    Politi, A
    Dimopoulos, M
    JOURNAL OF NEUROLOGY, 2005, 252 : 135 - 135
  • [49] Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma
    Wiesmann, A
    Einsele, H
    Kanz, L
    Dohmen, BM
    BONE MARROW TRANSPLANTATION, 2005, 36 (01) : 89 - 90
  • [50] Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma
    A Wiesmann
    H Einsele
    L Kanz
    B M Dohmen
    Bone Marrow Transplantation, 2005, 36 : 89 - 90
12345